Varicose Veins Treatment

Varicose Veins Treatment Market - Increase in the Incidence of Varicose Vein Disease is Expected to Lead to Market Growth – Growing at a Compound Annual Growth Rate (CAGR) 6.5% from 2022 to 2028

  • Varicose Veins Treatment Market

As stated in our extensive report, the Global Varicose Veins Treatment Market accounted forUSD 281.3 Millionin the year 2021.

The weakening of the vessel walls causes varicose veins, which are abnormally dilated blood vessels. Under the epidermis, these veins seemed bloated, twisted clusters of blue or purple veins. Millions of people all around the world suffer from varicose vein disease. Symptoms usually develop around the age of 40 and primarily affect the legs. If varicose veins cause venous stasis ulcers, phlebitis, thrombosis, venous bleeding, or fungal and bacterial infections, they are dangerous to one's health. According to the American Society of Vascular Surgery, at least 20 to 25 million Americans have varicose veins, with 17 percent of males and 33 percent of women suffering from the condition.

The varicose vein treatment report is based on in-depth primary and secondary research conducted regionally to determine the variables driving market growth and those impeding it. The market is driven by factors such as an increase in the incidence of varicose vein disease, an increase in the geriatric population, advanced varicose vein treatment devices, participation in occupations that increase the prevalence of varicose vein treatment and global technological advancements. Furthermore, as people become more aware of varicose veins and new markets develop, there is significant potential in the varicose vein therapy industry. Over the forecast period, the market is expected to rise because of the advent of ever less invasive treatment procedures and the growing geriatric demographic base.

North America is expected to dominate the Varicose Veins Treatment market in 2021, owing to the rising incidence of varicose vein cases, high disposable income, sophisticated healthcare infrastructure, increasing disorders, and an upward trend in the adoption of unhealthy lifestyles. In 2014, more than 40 million people in the United States got varicose vein treatment. In the United States, increased reimbursement rules are expected to drive the Varicose Veins Treatment market expansion.

Some of the key players in the Global Varicose Veins Treatment market include- Medtronic PLC (Ireland), AngioDynamics Inc. (U.S.), Biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton . (Italy), Vascular Solutions Inc. (U.S.), Quanta System . (Italy), Sciton Inc. (U.S.), Fotona . (Slovenia), BTG PLC (U.K.), Merz Aesthetics (U.S.), and others.